CV Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE

NET LOSS PER SHARE

3 Months Ended

Mar. 31, 2021

NET LOSS PER SHAREThe Company computes basic net loss per share using the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares plus potential common shares. The Company's stock options, including those with performance conditions, are included in the calculation of diluted net loss per share using the treasury stock method when their effect is dilutive. Potential common shares are excluded from the calculation of diluted net loss per share when their effect is anti-dilutive.

The following common stock equivalents were not included in the calculation of net loss per diluted share because their effect were anti-dilutive (in thousands):


	Three months ended March 31,
	2021	2020
Stock options	25,547	20,535
Performance stock options	5,000	5,000
Total	30,547	25,535

The above table excludes 8,000,000 unvested performance stock options for the three months ended March 31, 2021 and 2020, which vest upon the completion of future performance conditions.